MedPath

Daily REmote Ischaemic Conditioning Following Acute Myocardial Infarction

Not Applicable
Completed
Conditions
Post Myocardial Infarction
Interventions
Procedure: Remote Ischaemic Conditioning administered via the inflation of a blood pressure cuff on the upper arm
Procedure: Sham conditioning
Registration Number
NCT01664611
Lead Sponsor
University of Leicester
Brief Summary

Remote ischaemic conditioning (RIC) is known to reduce infarct size post MI when used in the peri/immediate post infarct period. However little is known as to the effect of repeated remote conditioning post-MI (Myocardial Infarction) on not only infarct size, but also on ventricular remodeling and ultimately cardiac failure. In this phase II first in man trial, the investigators intend to carry out daily remote ischaemic conditioning in post MI patients. The principal hypothesis is that RIC applied on a daily basis for 4 weeks following a heart attack improves the ejection fraction at 4 months as assessed by cardiac magnetic resonance imaging.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
90
Inclusion Criteria
  • LVEF < 45% on baseline ECHO
  • First STEMI
  • Successful revascularisation by PPCI
  • Able to attend regional centre for follow-up appointment
  • Competent to consent
Exclusion Criteria
  • < 18 of age
  • ICD or CRTP/D in-situ
  • Prior history of heart failure
  • Haemoglobin < 11.5 g/dl
  • Creatinine > 200 µmol/L (eGFR<30ml/min/m2)
  • Known malignancy/other comorbid condition which in the opinion of the investigator is likely to have significant negative influence on life expectancy
  • Significant complications/illness following MI
  • Unable to undergo cMRI
  • Further planned coronary interventions
  • Enrollment in another clinical trial

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Treatment armRemote Ischaemic Conditioning administered via the inflation of a blood pressure cuff on the upper armParticipants in this arm will receive remote ischaemic conditioning on a daily basis for 4 weeks post MI
Sham armSham conditioningParticipants in this arm will receive sham ischaemic conditioning on a daily basis for 4 weeks post MI
Primary Outcome Measures
NameTimeMethod
Mean change in LVEF from baseline to 4 months as assessed by cMRIParticipants will be followed for a total of 4 months from date of MI to final outpatient follow-up at which point they will be discharged. Primary outcome measure assessed at baseline and 4 months post MI.

Mean change in LVEF from baseline to 4 months as assessed by cMRI

Secondary Outcome Measures
NameTimeMethod
Mean blood biomarker levels of heart failure and ventricular remodelling at baseline and 4 monthsParticipants will be followed for a total of 4 months from date of MI to final outpatient follow-up at which point they will be discharged. Secondary outcome measure assessed at baseline and 4 months post MI.

Mean blood biomarker levels of heart failure and ventricular remodelling (e.g. NT-proBNP, MMP9, TIMP1) at baseline and 4 months

Final infarct size at 4 months as assessed by cMRIParticipants will be followed for a total of 4 months from date of MI to final outpatient follow-up at which point they will be discharged. Secondary outcome measure assessed at 4 months post MI.

Final infarct size at 4 months as assessed by cMRI

Mean KCCQ score at 4 monthsParticipants will be followed for a total of 4 months from date of MI to final outpatient follow-up at which point they will be discharged. Secondary outcome measure assessed at 4 months post MI.

Mean Kansas City Cardiomyopathy Screen (KCCQ) score at 4 months

Trial Locations

Locations (1)

Univesrity of Leicester, Department of Cardiovascular Science

🇬🇧

Leicester, Leicestershire, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath